Sign Up to like & get
recommendations!
0
Published in 2019 at "Circulation"
DOI: 10.1161/circulationaha.119.038770
Abstract: The cardiovascular community has been debating for decades whether to treat mild-tomoderate hypertriglyceridemia. Results of the Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial (REDUCE-IT)1 position this controversy as front matter for deliberation. For lipid…
read more here.
Keywords:
new beginning;
triglyceride lowering;
beginning triglyceride;
lowering therapies ... See more keywords